The FDA has issued a warning regarding compounded drugs distributed by Fullerton Wellness, LLC, in Ontario, California.

Cancer disparities are evident across the Human Development Index (HDI) and are projected to increase by 2050.

The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.

Soft multifocal lenses show promise as a management tool for accommodation and vergence disorders in patients without presbyopia.

There is a small inverse association between plasma omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) and cancer. HealthDay News — There is a small inverse association between plasma omega-6 and ...

A TRPM8 agonist that targets corneal sensory nerves can increase and sustain tear production in patients with dry eye disease.

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines. HealthDay News — Reactogenicity is comparable for simultaneous and sequential ...

Expanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor agonists could avert 42,000 deaths annually ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least ...

Sugar restriction during the first 1,000 days after conception lowers a child's risk for later developing type 2 diabetes and hypertension.

A drug-eluting contact lens that uses 3D printing technology can improve IOP and treatment compliance for patients with glaucoma.

Twice-weekly treatment with lifitegrast 5.0% can help alleviate discomfort and dryness in contact lens wearers.